We are live on ! Find out more
RNAM

Avidity Biosciences
RNAM

Delisted

RNAM was delisted on the 26th of February, 2026.

Back to rankings

67 hedge funds and large institutions have $755M invested in Avidity Biosciences in 2020 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 16

29% more funds holding

Funds holding: 52 → 67 (+15)

8% more capital invested

Capital invested by funds: $702M → $755M (+$53.6M)

4.13% more ownership

Funds ownership: 67.87% → 72% (+4.1%)

20% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 15

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
67
Holders Change
+15
Holders Change %
+28.85%
% of All Funds
1.35%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
31
Increased
12
Reduced
15
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
+$26.1M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$21.1M
3
BlackRock
BlackRock
New York
+$20.1M
4
PHS
PFM Health Sciences
California
+$12.7M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$7.33M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$11.6M
2
Citadel Advisors
Citadel Advisors
Florida
-$7.72M
3
Franklin Resources
Franklin Resources
California
-$7.11M
4
APM
Avidity Partners Management
Texas
-$6.64M
5
Millennium Management
Millennium Management
New York
-$6.39M
Name Holding Trade Value Shares
Change 		Change in
Stake
GGHC
51
Gilder Gagnon Howe & Co
New York
$277K -$4.97K -172 -2%
Westfield Capital Management
52
Westfield Capital Management
Massachusetts
$259K +$266K +9,200 New
Manulife (Manufacturers Life Insurance)
53
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$250K +$257K +8,888 New
New York State Common Retirement Fund
54
New York State Common Retirement Fund
New York
$214K +$220K +7,600 New
MIM
55
MetLife Investment Management
New Jersey
$208K +$214K +7,396 New
MFS
56
Mirabella Financial Services
United Kingdom
$204K +$210K +7,260 New
WCA
57
Windsor Creek Advisors
Vermont
$195K +$201K +6,942 New
JP Morgan Chase
58
JP Morgan Chase
New York
$180K +$180K +6,235 New
MLICM
59
Metropolitan Life Insurance Company (MetLife)
New York
$143K +$147K +5,077 New
Morgan Stanley
60
Morgan Stanley
New York
$142K +$146K +5,045 New
SO
61
STRS Ohio
Ohio
$118K +$121K +4,200 New
TRCT
62
Tower Research Capital (TRC)
New York
$74K +$76K +2,628 New
Legal & General Group
63
Legal & General Group
United Kingdom
$53K +$54.1K +1,871 New
BCV
64
Banque Cantonale Vaudoise
Switzerland
$45K +$46.2K +1,600 New
AIP
65
Ameritas Investment Partners
Nebraska
$40K +$41.2K +1,425 New
Bank of Montreal
66
Bank of Montreal
Ontario, Canada
$23K +$22.4K +775 New
Citigroup
67
Citigroup
New York
$23K +$23.2K +803 New
Franklin Resources
68
Franklin Resources
California
– -$7.11M -300,000 Closed
Citadel Advisors
69
Citadel Advisors
Florida
– -$7.72M -273,220 Closed
APM
70
Avidity Partners Management
Texas
– -$6.64M -234,814 Closed
Millennium Management
71
Millennium Management
New York
– -$6.39M -226,044 Closed
FCM
72
Farallon Capital Management
California
– -$1.41M -50,000 Closed
HM
73
HealthCor Management
New York
– -$1.41M -50,000 Closed
PCM
74
Pinz Capital Management
New York
– -$1.41M -50,000 Closed
MIM
75
Monashee Investment Management
Massachusetts
– -$1.13M -40,000 Closed
1 2
3
4

RNAM Hedge Fund Activity: Q3 2020 in Review

67 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Avidity Biosciences (RNAM) for Q3 2020, worth a combined $755M — up 7.6% from $702M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new RNAM positions and 16 closed out — a net gain of 15 holders — while 12 added to existing stakes and 15 trimmed.

The largest buyer was Federated Hermes, adding an estimated $26.1M. The largest seller was Deerfield Management, cutting an estimated $11.6M.

  • 67 institutional investors held Avidity Biosciences (RNAM) as of Q3 2020, up from 52 in Q2 2020.
  • Funds reported $755M of Avidity Biosciences stock for Q3 2020, up 7.6% quarter-over-quarter.
  • 31 funds opened new Avidity Biosciences positions in Q3 2020 and 16 closed out, a net change of +15 holders.
  • The largest Avidity Biosciences buyer in Q3 2020 was Federated Hermes, an estimated $26.1M added.
  • The largest Avidity Biosciences seller in Q3 2020 was Deerfield Management, an estimated $11.6M sold.

Based on aggregated 13F filings for Q3 2020.